Gut-lung axis: COPD patients have unique faecal microbiome signature

People with COPD have a unique gut microbiome signature that may provide a useful biomarker for the disease and also have potential for treatment targeting, Australian researchers say. A study led by scientists from the University of Queensland found significant variation in the faecal microbiome and metabolome of COPD patients and healthy controls, with 146 ...